User login
A trio of up-and-coming dermatologists received the La Roche-Posay North American Foundation’s 2014 Research Awards, presented at the annual meeting of the American Academy of Dermatology in Denver.
The awards were given to candidates with promising projects in clinical, biological, and pharmacological research linked to dermatology.
Dr. Thomas Strub of the Icahn School of Medicine at Mount Sinai, New York, received the first-place grant of $10,000 for his study "Epigenetic Mechanisms Underlying Drug Resistance of Malignant Melanoma."
"It is a privilege for me to be chosen by the La Roche-Posay North American Foundation for supporting my research goals," Dr. Strub said in a statement. "Melanoma therapies remain limited, and drug resistance invariably occurs, with patients ultimately relapsing. I hope my research will shed light onto the epigenome of resistant melanoma tumors and insight on the elements involved in melanoma, which will ultimately improve patient outcomes."
Dr. Shadmehr Demehri of Washington University, St. Louis, received the second prize of $5,000 for his study "The Role of Calcipotriol in Treatment of Pre-cancerous Skin Lesions."
"It’s a great honor to be a recipient of the La Roche-Posay North American Foundation’s research award," Dr. Demehri said in a statement. "My research focuses on determining the role of immune activation in cancer therapy. Specifically, I aim to understand the effects of epithelial cytokine expression on induction of antitumor immunity. Considering the rising prevalence of skin cancer in our population, the outcomes of our investigation can have significant impact on care for patients with skin and other types of cancers."
Dr. Emily Newsom of Wayne State University, Detroit, received the third prize award of $5,000 for her study "Mapping Cytogenetic Abnormalities in Cutaneous T-cell Lymphoma using FISH."
"I appreciate the La Roche-Posay North American Foundation’s commitment to furthering research in dermatology. This award will allow me to advance my career and research in cutaneous lymphoma," Dr. Newsom said in a statement.
The winners were selected by the La Roche-Posay North American Scientific Committee.
For additional information about La Roche-Posay, visit www.laroche-posay.us and "like" the La Roche-Posay Facebook page at www.facebook.com/LaRochePosayusa.
A trio of up-and-coming dermatologists received the La Roche-Posay North American Foundation’s 2014 Research Awards, presented at the annual meeting of the American Academy of Dermatology in Denver.
The awards were given to candidates with promising projects in clinical, biological, and pharmacological research linked to dermatology.
Dr. Thomas Strub of the Icahn School of Medicine at Mount Sinai, New York, received the first-place grant of $10,000 for his study "Epigenetic Mechanisms Underlying Drug Resistance of Malignant Melanoma."
"It is a privilege for me to be chosen by the La Roche-Posay North American Foundation for supporting my research goals," Dr. Strub said in a statement. "Melanoma therapies remain limited, and drug resistance invariably occurs, with patients ultimately relapsing. I hope my research will shed light onto the epigenome of resistant melanoma tumors and insight on the elements involved in melanoma, which will ultimately improve patient outcomes."
Dr. Shadmehr Demehri of Washington University, St. Louis, received the second prize of $5,000 for his study "The Role of Calcipotriol in Treatment of Pre-cancerous Skin Lesions."
"It’s a great honor to be a recipient of the La Roche-Posay North American Foundation’s research award," Dr. Demehri said in a statement. "My research focuses on determining the role of immune activation in cancer therapy. Specifically, I aim to understand the effects of epithelial cytokine expression on induction of antitumor immunity. Considering the rising prevalence of skin cancer in our population, the outcomes of our investigation can have significant impact on care for patients with skin and other types of cancers."
Dr. Emily Newsom of Wayne State University, Detroit, received the third prize award of $5,000 for her study "Mapping Cytogenetic Abnormalities in Cutaneous T-cell Lymphoma using FISH."
"I appreciate the La Roche-Posay North American Foundation’s commitment to furthering research in dermatology. This award will allow me to advance my career and research in cutaneous lymphoma," Dr. Newsom said in a statement.
The winners were selected by the La Roche-Posay North American Scientific Committee.
For additional information about La Roche-Posay, visit www.laroche-posay.us and "like" the La Roche-Posay Facebook page at www.facebook.com/LaRochePosayusa.
A trio of up-and-coming dermatologists received the La Roche-Posay North American Foundation’s 2014 Research Awards, presented at the annual meeting of the American Academy of Dermatology in Denver.
The awards were given to candidates with promising projects in clinical, biological, and pharmacological research linked to dermatology.
Dr. Thomas Strub of the Icahn School of Medicine at Mount Sinai, New York, received the first-place grant of $10,000 for his study "Epigenetic Mechanisms Underlying Drug Resistance of Malignant Melanoma."
"It is a privilege for me to be chosen by the La Roche-Posay North American Foundation for supporting my research goals," Dr. Strub said in a statement. "Melanoma therapies remain limited, and drug resistance invariably occurs, with patients ultimately relapsing. I hope my research will shed light onto the epigenome of resistant melanoma tumors and insight on the elements involved in melanoma, which will ultimately improve patient outcomes."
Dr. Shadmehr Demehri of Washington University, St. Louis, received the second prize of $5,000 for his study "The Role of Calcipotriol in Treatment of Pre-cancerous Skin Lesions."
"It’s a great honor to be a recipient of the La Roche-Posay North American Foundation’s research award," Dr. Demehri said in a statement. "My research focuses on determining the role of immune activation in cancer therapy. Specifically, I aim to understand the effects of epithelial cytokine expression on induction of antitumor immunity. Considering the rising prevalence of skin cancer in our population, the outcomes of our investigation can have significant impact on care for patients with skin and other types of cancers."
Dr. Emily Newsom of Wayne State University, Detroit, received the third prize award of $5,000 for her study "Mapping Cytogenetic Abnormalities in Cutaneous T-cell Lymphoma using FISH."
"I appreciate the La Roche-Posay North American Foundation’s commitment to furthering research in dermatology. This award will allow me to advance my career and research in cutaneous lymphoma," Dr. Newsom said in a statement.
The winners were selected by the La Roche-Posay North American Scientific Committee.
For additional information about La Roche-Posay, visit www.laroche-posay.us and "like" the La Roche-Posay Facebook page at www.facebook.com/LaRochePosayusa.